SIETES :: 92751 citas

Resultados de la búsqueda por ESTONIA REFINAR BÚSQUEDA

1.

Anónimo. Saccharomyces boulardii probiotics: Do not use in critically ill or immunocompromised patients. Estonia . WHO Drug Information 2018;32:19. [Ref.ID 102623]

2.

Socías ME, Wood E. Epidemic of deaths from fentanyl overdose. BMJ 2017;359:j4355. [Ref.ID 102107]

3.

Chang S-S, Stuckler D, Yip P, Gunnell D. Impact of 2008 global economic crisis on suicide: time trend study in 54 countries. BMJ 2013;347:13. [Ref.ID 96258]

4.

Hawton K, Haw C. Economic recession and suicide. BMJ 2013;347:9. [Ref.ID 96256]

5.

Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, Dwyer-Lindgren L, Lofgren KT, Phillips D, Atkinson C, Lopez AD, Murray CJL. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 2011;378:1139-65. [Ref.ID 91511]

6.

Byass P, Graham WJ. Grappling with uncertainties along the MDG trail. Lancet 2011;378:1119-20. [Ref.ID 91510]

7.

Rajaratnam JK, Marcus JR, Levin-Rector A, Chalupka AN, Wang H, Dwyer L, Costa M, López AD, Murray CJL. Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet 2010;375:1704-20. [Ref.ID 88504]

8.

Koyanagi A, Shibuya K. What do we really know about adult mortality worldwide?. Lancet 2010;375:1668-70. [Ref.ID 88501]

9.

Hogan MC, Foreman KJ, Nagavi M, Ahn SY, Wang M, Makela SM, López AD, Lozano R, Murray CJL. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010;375:1609-23. [Ref.ID 88495]

10.

Watson R. 15% of antibiotic sales in Greece are over the counter. BMJ 2010;340:886-7. [Ref.ID 88385]

11.

Doyle Y. Meeting the challenge of population ageing. BMJ 2009;339:892-4. [Ref.ID 86971]

12.

Jagger C, Gillies C, Moscone F, Cambois E, Van Oyen H, Nusselder W, Robine J-M, and the EHLEIS team. Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-natinoal meta-regression analysis. Lancet 2008;372:2124-31. [Ref.ID 84787]

13.

Dobson R. Northern Ireland's use of antibiotics is a third higher than in England. BMJ 2008;337:780-1. [Ref.ID 84137]

14.

Sethi D, Racioppi F, Baumgarten I, Bertollini R. Reducing inequalities from injuries in Europe. Lancet 2007;368:2243-50. [Ref.ID 78725]

15.

Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, Williams H, and the ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43. [Ref.ID 77954]

16.

Anónimo. Cardiovascular drugs cost Europe €28.4 billion. Scrip 2006;3137:3. [Ref.ID 76276]

17.

Vägerö D, Leinsalu M. Commentary: Health inequalities and social dynamics in Europe. BMJ 2005;331:186-7. [Ref.ID 74435]

18.

Lawlor DA, Harro M, Wedderkopp N, Andersen LB, Sardinha LB, Riddoch CJ, Page AS, Anderssen SA, Froberg K, Stansbie D, Smith GD. Association of socioeconomic position with insulin resistance among children from Denmark, Estonia, and Portugal: cross sectional study. BMJ 2005;331:183-7. [Ref.ID 74434]

19.

Goossens H, Ferech M, Stichele RV, Elseviers M, for the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87. [Ref.ID 72922]

20.

Turnidge J, Christiansen K. Antibiotic use and resistance - proving the obvious. Lancet 2005;365:548-9. [Ref.ID 72914]